The possible relation between MS and prostate cancer has been proposed to be an increase in sympathetic activity, which drives prostate gland growth [62], and a dysregulation in the production of specific cytokines, IGF-1, which disrupts the prostate’s normal functioning [63]. This evidence concerns the gene IGF1 and prostate carcinoma.